Literature DB >> 31576305

Stereotactic body radiation therapy for oligometastatic renal cell carcinoma: improving outcomes in an otherwise radioresistant malignancy.

Thomas H Beckham1, Brandon S Imber1, Charles B Simone1,2.   

Abstract

Entities:  

Year:  2019        PMID: 31576305      PMCID: PMC6685837          DOI: 10.21037/atm.2019.04.58

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  25 in total

Review 1.  Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy.

Authors:  Jason K Molitoris; Tejan Diwanji; James W Snider; Sina Mossahebi; Santanu Samanta; Nasarachi Onyeuku; Pranshu Mohindra; J Isabelle Choi; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2019-02

2.  Cytoreductive Nephrectomy in Metastatic Renal Cell Cancer: Not All That It's Cut Out to Be.

Authors:  Primo N Lara; Christopher P Evans
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

3.  Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Harras B Zaid; William P Parker; Nida S Safdar; Boris Gershman; Patricia J Erwin; M Hassan Murad; Stephen A Boorjian; Brian A Costello; R Houston Thompson; Bradley C Leibovich
Journal:  J Urol       Date:  2016-07-26       Impact factor: 7.450

4.  Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.

Authors:  Bimal Bhindi; E Jason Abel; Laurence Albiges; Karim Bensalah; Stephen A Boorjian; Siamak Daneshmand; Jose A Karam; Ross J Mason; Thomas Powles; Axel Bex
Journal:  Eur Urol       Date:  2018-10-25       Impact factor: 20.096

5.  Single fraction radiosurgery for the treatment of renal tumors.

Authors:  Michael Staehler; Markus Bader; Boris Schlenker; Jozefina Casuscelli; Alexander Karl; Alexander Roosen; Christian G Stief; Axel Bex; Berndt Wowra; Alexander Muacevic
Journal:  J Urol       Date:  2014-08-14       Impact factor: 7.450

6.  Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials.

Authors:  M A Tunio; A Hashmi; M Rafi
Journal:  Ann Oncol       Date:  2010-02-05       Impact factor: 32.976

7.  Resection of metastatic renal cell carcinoma.

Authors:  J P Kavolius; D P Mastorakos; C Pavlovich; P Russo; M E Burt; M S Brady
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

8.  Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Authors:  Robert C Flanigan; G Mickisch; Richard Sylvester; Cathy Tangen; H Van Poppel; E David Crawford
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

9.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Authors:  Arnaud Méjean; Alain Ravaud; Simon Thezenas; Sandra Colas; Jean-Baptiste Beauval; Karim Bensalah; Lionnel Geoffrois; Antoine Thiery-Vuillemin; Luc Cormier; Hervé Lang; Laurent Guy; Gwenaelle Gravis; Frederic Rolland; Claude Linassier; Eric Lechevallier; Christian Beisland; Michael Aitchison; Stephane Oudard; Jean-Jacques Patard; Christine Theodore; Christine Chevreau; Brigitte Laguerre; Jacques Hubert; Marine Gross-Goupil; Jean-Christophe Bernhard; Laurence Albiges; Marc-Olivier Timsit; Thierry Lebret; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

10.  Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.

Authors:  Sean P Pitroda; Nikolai N Khodarev; Lei Huang; Abhineet Uppal; Sean C Wightman; Sabha Ganai; Nora Joseph; Jason Pitt; Miguel Brown; Martin Forde; Kathy Mangold; Lai Xue; Christopher Weber; Jeremy P Segal; Sabah Kadri; Melinda E Stack; Sajid Khan; Philip Paty; Karen Kaul; Jorge Andrade; Kevin P White; Mark Talamonti; Mitchell C Posner; Samuel Hellman; Ralph R Weichselbaum
Journal:  Nat Commun       Date:  2018-05-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.